Cushing's Disease | sciencenewsnet.in

Breaking News

Additional comments on extracellular vesicles derived from mesenchymal stem cells mediate extracellular matrix remodeling in osteoarthritis

Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury

Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease

Study finds targeting inflammation may not help reduce liver fibrosis in MAFLD

UF scientists study how to bring you ‘climate-smart coffee’

Moffitt Study Uncovers Key Immune Cells for Combating Aggressive Merkel Cell Carcinoma

Chula hosted “The Second Chulalongkorn University President’s Distinguished Speakers” a Special Lecture on “Revolutionizing the Future: An Exclusive Talk with “Andrew Ng” on Opportunities and Business Preparedness” by the World’s Influential AI Exper

Cleaning the window of opportunity: Towards a typology of sustainability entrepreneurs

Does information disclosure alleviate overcrowding? An empirical study based on large-scale COVID-19 nucleic acid test

Researchers develop state-of-the-art device to make artificial intelligence more energy efficient

27 Jul, 2024

Meditating with headband that tracks brain activity may improve surgical recovery in patients with Cushing’s

June 3, 2024 sarah JonasResearch Results

Patients with Cushing’s syndrome who are recovering from surgery and wear a headband that tracks brain activity while they meditate may have less pain and better physical functioning compared with patients not using the device, suggests a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Remission of Cushing’s disease associated with higher risk of developing autoimmune disease

February 19, 2024 sarah JonasResearch Results

A study of more than 250 persons undergoing surgical therapy for Cushing’s disease (CD) or nonfunctioning pituitary adenomas (NFPAs) found that patients who achieved remission of CD were more likely than those with surgically treated NFPAs to develop new-onset autoimmune disease within 3 years after remission. The study is published in Annals of Internal Medicine.